Лихорадка как отправная точка в диагностическом поиске. Выбор жаропонижающего препарата
Лихорадка как отправная точка в диагностическом поиске. Выбор жаропонижающего препарата
Делягин В.М. Лихорадка как отправная точка в диагностическом поиске. Выбор жаропонижающего препарата. Consilium Medicum. Педиатрия (Прил.). 2015; 1: 80–85.
________________________________________________
Delyagin V.M. Fever as a starting point in the diagnostic search. The choice of antipyretic drugs. Consilium Medicum. Pediatrics (Suppl.).2015; 1: 80–85.
Лихорадка как отправная точка в диагностическом поиске. Выбор жаропонижающего препарата
Делягин В.М. Лихорадка как отправная точка в диагностическом поиске. Выбор жаропонижающего препарата. Consilium Medicum. Педиатрия (Прил.). 2015; 1: 80–85.
________________________________________________
Delyagin V.M. Fever as a starting point in the diagnostic search. The choice of antipyretic drugs. Consilium Medicum. Pediatrics (Suppl.).2015; 1: 80–85.
Повышение температуры – естественная физиологическая реакция на воспаление. В практике педиатра это чаще всего респираторные вирусные инфекции. Задача врача – провести своевременную дифференциальную диагностику и выбрать оптимальные схемы симптоматического и при необходимости этиопатогенетического лечения. В качестве жаропонижающего средства препаратом выбора является ибупрофен. Препарат отличается высоким профилем эффективности и безопасности, скоростью наступления и длительностью эффекта. Выбор дополнительно обосновывают наличие различных лекарственных форм препарата и возможность применения у детей с атопией.
An increase in temperature – a natural physiological response to inflammation. In pediatric practice is often a viral respiratory infection. The doctor's task – to conduct timely differential diagnosis and to choose the optimal scheme of symptomatic and, if necessary, etiopathogenetic treatment. As an antipyretic drug of choice is ibuprofen. The drug has a rapid, efficient and long-lasting effect. Selecting further substantiate the existence of various dosage forms of the drug and the possibility of use in children with atopy.
1. Luszczak M. Evaluation and management of infants and young children with fever. Am Fam Physician 2001; 64: 1219–26.
2. Hay W, Hayward A, Lewin M. (eds.) Current pediatric diagnosis and treatment. 16th ed. McGraw Hill. NY 2003; p. 237–9.
3. Green R, Allergoll D, Ktze S, Lewis H et al. Management of acute fever in children: Guideline for community healthcare providers and pharmacists. S Afr Med J 2013; 103 (12): 948–54.
4. Temperature measurements in children. http://www.cps.ca/english/ statements/CP/cp00-01.htm
5. Feverish illness in children. Assessment and initial management in children younger then 5 years. NICE clinical guideline 47 developed by the national collaborating centre for womens and children health, 2007.
6. Ferri F. Seizures Febrile. In: Ferris Clinical Adviser. Mosby 2015; p. 1062.
7. Vinh H, Parry C, Hangh V et al. Double blend comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever. Pediatr Infect Dis J 2004; 23: 226–30.
8. Manley J, Taddio A. Acetaminophen and ibuprofen for prevention of adverse reaction associated with childhood immunization. Ann Pharmacother 2007; 41: 1227–32.
9. Sulvivan J, Farrar H. Clinical report – fever and antipyretic use in children. Pediatrics 2011; 127: 581–7.
10. Плоскарева А.А., Петухова Е.В. Лихорадка у детей: современный взгляд на терапевтическую тактику. Consilium Medicum. Педиатрия (Прил.). 2014; 4: 70–3. / Ploskareva A.A., Petukhova E.V. Likhoradka u detei: sovremennyi vzgliad na terapevticheskuiu taktiku. Consilium Medicum. Pediatriia (Pril.). 2014; 4: 70–3. [in Russian]
11. Учайкин В.Ф., Харламова Ф.С., Легкова Т.П. и др. Клиническая эффективность терапии Нурофеном при респираторных заболеваниях, сопровождающихся острым стенозирующим ларинготрахеитом, у детей. Педиатрия. Журн. им. Г.Н.Сперанского. 2013; 6: 94–100. / Uchaikin V.F., Kharlamova F.S., Legkova T.P. i dr. Klinicheskaia effektivnost' terapii Nurofenom pri respiratornykh zabolevaniiakh, soprovozhdaiushchikhsia ostrym stenoziruiushchim laringotrakheitom, u detei. Pediatriia. Zhurn. im. G.N.Speranskogo. 2013; 6: 94–100. [in Russian]
12. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109 (2): e20.
13. The management of fever in young children with acute respiratory infections in developing countries. WHO/ARI/93.90. Geneva, 1993.
14. McBride JT. The association of acetaminophen and asthma prevalence and severity. Pediatrics 2011; 128 (6): 1181–5.
15. Etminan M, Sadatsafavi M, Jafari S et al. Acetaminophen use and the risk of asthma in children and adults: a systematic review and meta-analysis. Chest 2009; 136 (5): 1316–23.
16. Beasley R, Clayton T, Crane J et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372: 1039–48.
17. Kanabar D, Dale S, Rawat M. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms. Clin Ther 2007; 29 (12): 2123–716.
18. Шифман Е.М., Ершов А.Л. Парацетамол: терапевтическое применение и проблема острых отравлений. Общая реаниматология. 2007; 3: 1. / Shifman E.M., Ershov A.L. Paratsetamol: terapevticheskoe primenenie i problema ostrykh otravlenii. Obshchaia reanimatologiia. 2007; 3: 1. [in Russian]
19. Anderson B. Paracetamol. In: E.Jacqz-Aigrain, I.Choonara, ed. Paediatric Clin Pharmacol 2006; NY: Taylor & Francis; p. 621–7.
20. Bilenko N, Tessler H, Okbe R et al. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study. Clin Ther 2006; 28 (5): 783–93.
21. Ушкалова Е.А. Анальгетики-антипиретики и нестероидные противовоспалительные средства в педиатрии: соотношение польза/риск и влияние на течение аллергических заболеваний. Consilium Medicum. Педиатрия (Прил.). 2013; 3: 70–5. / Ushkalova E.A. Anal'getiki-antipiretiki i nesteroidnye protivovospalitel'nye sredstva v pediatrii: sootnoshenie pol'za/risk i vliianie na techenie allergicheskikh zabolevanii. Consilium Medicum. Pediatriia (Pril.). 2013; 3: 70–5. [in Russian]
22. Farrel S. Acetaminophen toxicity. E-Medicine. Updated: Jun 24, 2014; http://emedicine.medscape.com/article/820200-overview
23. Ушкалова Е.А. Лекарственные поражения печени. Фарматека. 2003; 10. / Ushkalova E.A. Lekarstvennye porazheniia pecheni. Farmateka. 2003; 10. [in Russian]
24. Goldfrank LR, Flomenbaum NE, Lewin NA et al. Goldfrank's Toxicologic Emergencies, 7th. McGraw-Hill, NY 2002.
25. Roche C, Ragot C, Moalic J et al. Ibuprofen can induce syndrome of inappriate diuresis in healthy young patients. Case Rep Med 2013; http://doi:10.1155/2013/167267
26. Тимченко В.Н., Павлова Е.Б. Применение ибупрофена (суппозитории ректальные) в терапии различной инфекционной патологии у детей раннего возраста. Лечащий врач. 2011; 6. / Timchenko V.N., Pavlova E.B. Primenenie ibuprofena (suppozitorii rektal'nye) v terapii razlichnoi infektsionnoi patologii u detei rannego vozrasta. Lechashchii vrach. 2011; 6. [in Russian]
27. American Academy of Pediatrics Committee on Drugs. Acetaminophen toxicity in children. Pediatrics. 2001; 108 (4): 1020–4.
28. Anderson B. Paracetamol. In: Jacqz-Aigrain E, Choonara I, editors. Paediatric Clinical Pharmacology. New York: Taylor & Francis, 2006: 621–7.
29. Osterhoudt KC, Henretig FM. Still Wary of Rectal Acetaminophen. Arch Pediatr Adolesc. Med 2009; 163 (5): 491.
30. Bilenko N, Tessler H, Okbe R et al. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study. Clin Ther 2006; 28 (5): 783–93.
________________________________________________
1. Luszczak M. Evaluation and management of infants and young children with fever. Am Fam Physician 2001; 64: 1219–26.
2. Hay W, Hayward A, Lewin M. (eds.) Current pediatric diagnosis and treatment. 16th ed. McGraw Hill. NY 2003; p. 237–9.
3. Green R, Allergoll D, Ktze S, Lewis H et al. Management of acute fever in children: Guideline for community healthcare providers and pharmacists. S Afr Med J 2013; 103 (12): 948–54.
4. Temperature measurements in children. http://www.cps.ca/english/ statements/CP/cp00-01.htm
5. Feverish illness in children. Assessment and initial management in children younger then 5 years. NICE clinical guideline 47 developed by the national collaborating centre for womens and children health, 2007.
6. Ferri F. Seizures Febrile. In: Ferris Clinical Adviser. Mosby 2015; p. 1062.
7. Vinh H, Parry C, Hangh V et al. Double blend comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever. Pediatr Infect Dis J 2004; 23: 226–30.
8. Manley J, Taddio A. Acetaminophen and ibuprofen for prevention of adverse reaction associated with childhood immunization. Ann Pharmacother 2007; 41: 1227–32.
9. Sulvivan J, Farrar H. Clinical report – fever and antipyretic use in children. Pediatrics 2011; 127: 581–7.
10. Ploskareva A.A., Petukhova E.V. Likhoradka u detei: sovremennyi vzgliad na terapevticheskuiu taktiku. Consilium Medicum. Pediatriia (Pril.). 2014; 4: 70–3. [in Russian]
11. Uchaikin V.F., Kharlamova F.S., Legkova T.P. i dr. Klinicheskaia effektivnost' terapii Nurofenom pri respiratornykh zabolevaniiakh, soprovozhdaiushchikhsia ostrym stenoziruiushchim laringotrakheitom, u detei. Pediatriia. Zhurn. im. G.N.Speranskogo. 2013; 6: 94–100. [in Russian]
12. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109 (2): e20.
13. The management of fever in young children with acute respiratory infections in developing countries. WHO/ARI/93.90. Geneva, 1993.
14. McBride JT. The association of acetaminophen and asthma prevalence and severity. Pediatrics 2011; 128 (6): 1181–5.
15. Etminan M, Sadatsafavi M, Jafari S et al. Acetaminophen use and the risk of asthma in children and adults: a systematic review and meta-analysis. Chest 2009; 136 (5): 1316–23.
16. Beasley R, Clayton T, Crane J et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372: 1039–48.
17. Kanabar D, Dale S, Rawat M. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms. Clin Ther 2007; 29 (12): 2123–716.
18. Shifman E.M., Ershov A.L. Paratsetamol: terapevticheskoe primenenie i problema ostrykh otravlenii. Obshchaia reanimatologiia. 2007; 3: 1. [in Russian]
19. Anderson B. Paracetamol. In: E.Jacqz-Aigrain, I.Choonara, ed. Paediatric Clin Pharmacol 2006; NY: Taylor & Francis; p. 621–7.
20. Bilenko N, Tessler H, Okbe R et al. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study. Clin Ther 2006; 28 (5): 783–93.
21. Ushkalova E.A. Anal'getiki-antipiretiki i nesteroidnye protivovospalitel'nye sredstva v pediatrii: sootnoshenie pol'za/risk i vliianie na techenie allergicheskikh zabolevanii. Consilium Medicum. Pediatriia (Pril.). 2013; 3: 70–5. [in Russian]
22. Farrel S. Acetaminophen toxicity. E-Medicine. Updated: Jun 24, 2014; http://emedicine.medscape.com/article/820200-overview
23. Ushkalova E.A. Lekarstvennye porazheniia pecheni. Farmateka. 2003; 10. [in Russian]
24. Goldfrank LR, Flomenbaum NE, Lewin NA et al. Goldfrank's Toxicologic Emergencies, 7th. McGraw-Hill, NY 2002.
25. Roche C, Ragot C, Moalic J et al. Ibuprofen can induce syndrome of inappriate diuresis in healthy young patients. Case Rep Med 2013; http://doi:10.1155/2013/167267
26. Timchenko V.N., Pavlova E.B. Primenenie ibuprofena (suppozitorii rektal'nye) v terapii razlichnoi infektsionnoi patologii u detei rannego vozrasta. Lechashchii vrach. 2011; 6. [in Russian]
27. American Academy of Pediatrics Committee on Drugs. Acetaminophen toxicity in children. Pediatrics. 2001; 108 (4): 1020–4.
28. Anderson B. Paracetamol. In: Jacqz-Aigrain E, Choonara I, editors. Paediatric Clinical Pharmacology. New York: Taylor & Francis, 2006: 621–7.
29. Osterhoudt KC, Henretig FM. Still Wary of Rectal Acetaminophen. Arch Pediatr Adolesc. Med 2009; 163 (5): 491.
30. Bilenko N, Tessler H, Okbe R et al. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study. Clin Ther 2006; 28 (5): 783–93.
Авторы
В.М.Делягин*
ФГБУ Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Д.Рогачева Минздрава России. 117997, Россия, Москва, ул. Саморы Машела, д. 1, ГСП-7;
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
*delyagin-doktor@yandex.ru
________________________________________________
V.M.Delyagin*
D.Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Samory Mashela, d. 1, GSP-7;
N.I.Pirogov Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*delyagin-doktor@yandex.ru